TROSPIUM CHLORIDE and INSOMNIA

45 reports of this reaction

0.9% of all TROSPIUM CHLORIDE reports

#40 most reported adverse reaction

Overview

INSOMNIA is the #40 most commonly reported adverse reaction for TROSPIUM CHLORIDE, manufactured by Padagis US LLC. There are 45 FDA adverse event reports linking TROSPIUM CHLORIDE to INSOMNIA. This represents approximately 0.9% of all 4,882 adverse event reports for this drug.

TROSPIUM CHLORIDE has an overall safety score of 72 out of 100. Patients taking TROSPIUM CHLORIDE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INSOMNIA45 of 4,882 reports

INSOMNIA is a less commonly reported adverse event for TROSPIUM CHLORIDE, but still significant enough to appear in the safety profile.

Other Side Effects of TROSPIUM CHLORIDE

In addition to insomnia, the following adverse reactions have been reported for TROSPIUM CHLORIDE:

Frequently Asked Questions

Does TROSPIUM CHLORIDE cause INSOMNIA?

INSOMNIA has been reported as an adverse event in 45 FDA reports for TROSPIUM CHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INSOMNIA with TROSPIUM CHLORIDE?

INSOMNIA accounts for approximately 0.9% of all adverse event reports for TROSPIUM CHLORIDE, making it a notable side effect.

What should I do if I experience INSOMNIA while taking TROSPIUM CHLORIDE?

If you experience insomnia while taking TROSPIUM CHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.